Crossmark

Industrializing rare disease therapy discovery and development

Crossref DOI link: https://doi.org/10.1038/nbt.3787

Published Online: 2017-02-01

Published Print: 2017-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ekins, Sean https://orcid.org/0000-0002-5691-5790
License Information

Text and Data Mining valid from 2017-02-01
More Information

Article History

First Online: 1 February 2017

Competing interests

: S.E. is a co-founder and employee of Collaborations Pharmaceuticals, Inc. and Phoenix Nest and consults for the Hereditary Neuropathy Foundation.